vs
Dave Inc.（DAVE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Dave Inc.的1.2倍（$197.9M vs $163.7M），Dave Inc.净利率更高（40.3% vs 6.7%，领先33.6%），Dave Inc.同比增速更快（62.4% vs 13.6%），Dave Inc.自由现金流更多（$289.7M vs $17.6M），过去两年Dave Inc.的营收复合增速更高（49.1% vs 14.4%）
Dave & Buster's是总部位于美国达拉斯的餐饮娱乐连锁品牌，旗下门店均配套全服务餐厅、酒吧，以及名为“百万美元中途岛”的电子游戏厅。截至2024年2月，品牌在美国拥有158家门店，波多黎各和加拿大各设有2家门店。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DAVE vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$163.7M
营收增速更快
DAVE
高出48.7%
13.6%
净利率更高
DAVE
高出33.6%
6.7%
自由现金流更多
DAVE
多$272.2M
$17.6M
两年增速更快
DAVE
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $163.7M | $197.9M |
| 净利润 | $65.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 39.2% | 9.0% |
| 净利率 | 40.3% | 6.7% |
| 营收同比 | 62.4% | 13.6% |
| 净利润同比 | 292.4% | 143.9% |
| 每股收益（稀释后） | $4.60 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAVERGEN
| Q4 25 | $163.7M | $197.9M | ||
| Q3 25 | $150.7M | $188.8M | ||
| Q2 25 | $131.8M | $182.4M | ||
| Q1 25 | $108.0M | $169.2M | ||
| Q4 24 | $100.8M | $174.1M | ||
| Q3 24 | $92.5M | $154.9M | ||
| Q2 24 | $80.1M | $154.1M | ||
| Q1 24 | $73.6M | $151.3M |
净利润DAVERGEN
| Q4 25 | $65.9M | $13.3M | ||
| Q3 25 | $92.1M | $14.9M | ||
| Q2 25 | $9.0M | $14.9M | ||
| Q1 25 | $28.8M | $5.8M | ||
| Q4 24 | $16.8M | $-30.3M | ||
| Q3 24 | $466.0K | $-654.0K | ||
| Q2 24 | $6.4M | $3.3M | ||
| Q1 24 | $34.2M | $2.1M |
毛利率DAVERGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率DAVERGEN
| Q4 25 | 39.2% | 9.0% | ||
| Q3 25 | 38.8% | 8.9% | ||
| Q2 25 | 8.7% | 7.6% | ||
| Q1 25 | 31.4% | 3.9% | ||
| Q4 24 | 17.3% | -17.7% | ||
| Q3 24 | 0.9% | -5.1% | ||
| Q2 24 | 5.7% | 1.0% | ||
| Q1 24 | 50.9% | 1.3% |
净利率DAVERGEN
| Q4 25 | 40.3% | 6.7% | ||
| Q3 25 | 61.1% | 7.9% | ||
| Q2 25 | 6.9% | 8.2% | ||
| Q1 25 | 26.7% | 3.4% | ||
| Q4 24 | 16.7% | -17.4% | ||
| Q3 24 | 0.5% | -0.4% | ||
| Q2 24 | 7.9% | 2.2% | ||
| Q1 24 | 46.5% | 1.4% |
每股收益（稀释后）DAVERGEN
| Q4 25 | $4.60 | $0.24 | ||
| Q3 25 | $6.34 | $0.26 | ||
| Q2 25 | $0.62 | $0.26 | ||
| Q1 25 | $1.97 | $0.10 | ||
| Q4 24 | $1.09 | $-0.55 | ||
| Q3 24 | $0.03 | $-0.01 | ||
| Q2 24 | $0.47 | $0.06 | ||
| Q1 24 | $2.60 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $767.6M |
| 总债务越低越好 | $0 | $542.2M |
| 股东权益账面价值 | $352.7M | $2.1B |
| 总资产 | $487.4M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DAVERGEN
| Q4 25 | $80.5M | $767.6M | ||
| Q3 25 | $49.9M | $748.7M | ||
| Q2 25 | $61.8M | $708.9M | ||
| Q1 25 | $47.1M | $697.2M | ||
| Q4 24 | $49.8M | $757.4M | ||
| Q3 24 | $35.2M | $784.0M | ||
| Q2 24 | $48.7M | $809.1M | ||
| Q1 24 | $56.6M | $780.6M |
总债务DAVERGEN
| Q4 25 | $0 | $542.2M | ||
| Q3 25 | $75.0M | $537.9M | ||
| Q2 25 | $75.0M | — | ||
| Q1 25 | $75.0M | — | ||
| Q4 24 | $75.0M | $525.6M | ||
| Q3 24 | $75.0M | — | ||
| Q2 24 | $75.0M | — | ||
| Q1 24 | $75.0M | — |
股东权益DAVERGEN
| Q4 25 | $352.7M | $2.1B | ||
| Q3 25 | $291.3M | $2.1B | ||
| Q2 25 | $217.1M | $2.1B | ||
| Q1 25 | $199.5M | $2.0B | ||
| Q4 24 | $183.1M | $2.0B | ||
| Q3 24 | $155.8M | $2.0B | ||
| Q2 24 | $141.8M | $2.0B | ||
| Q1 24 | $127.3M | $2.0B |
总资产DAVERGEN
| Q4 25 | $487.4M | $2.9B | ||
| Q3 25 | $433.3M | $2.9B | ||
| Q2 25 | $363.6M | $2.9B | ||
| Q1 25 | $315.7M | $2.9B | ||
| Q4 24 | $299.3M | $2.8B | ||
| Q3 24 | $272.2M | $2.8B | ||
| Q2 24 | $247.2M | $2.9B | ||
| Q1 24 | $235.6M | $2.8B |
负债/权益比DAVERGEN
| Q4 25 | 0.00× | 0.26× | ||
| Q3 25 | 0.26× | 0.26× | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.38× | — | ||
| Q4 24 | 0.41× | 0.27× | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $290.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $289.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 177.0% | 8.9% |
| 资本支出强度资本支出/营收 | 0.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.40× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $486.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流DAVERGEN
| Q4 25 | $290.0M | $25.7M | ||
| Q3 25 | $83.2M | $48.1M | ||
| Q2 25 | $68.2M | $28.6M | ||
| Q1 25 | $45.2M | $15.0M | ||
| Q4 24 | $125.1M | $39.2M | ||
| Q3 24 | $37.0M | $49.3M | ||
| Q2 24 | $28.0M | $42.2M | ||
| Q1 24 | $18.3M | $44.7M |
自由现金流DAVERGEN
| Q4 25 | $289.7M | $17.6M | ||
| Q3 25 | $83.2M | $43.4M | ||
| Q2 25 | $68.1M | $21.5M | ||
| Q1 25 | $45.2M | $11.4M | ||
| Q4 24 | $124.9M | $33.6M | ||
| Q3 24 | $37.0M | $42.3M | ||
| Q2 24 | $27.9M | $37.4M | ||
| Q1 24 | $18.3M | $36.4M |
自由现金流率DAVERGEN
| Q4 25 | 177.0% | 8.9% | ||
| Q3 25 | 55.2% | 23.0% | ||
| Q2 25 | 51.7% | 11.8% | ||
| Q1 25 | 41.9% | 6.8% | ||
| Q4 24 | 123.8% | 19.3% | ||
| Q3 24 | 40.0% | 27.3% | ||
| Q2 24 | 34.8% | 24.3% | ||
| Q1 24 | 24.9% | 24.0% |
资本支出强度DAVERGEN
| Q4 25 | 0.2% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.3% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% | ||
| Q1 24 | 0.0% | 5.5% |
现金转化率DAVERGEN
| Q4 25 | 4.40× | 1.93× | ||
| Q3 25 | 0.90× | 3.23× | ||
| Q2 25 | 7.55× | 1.92× | ||
| Q1 25 | 1.57× | 2.57× | ||
| Q4 24 | 7.45× | — | ||
| Q3 24 | 79.47× | — | ||
| Q2 24 | 4.41× | 12.70× | ||
| Q1 24 | 0.54× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAVE
| Service Based Revenue | $153.2M | 94% |
| Interchange Revenue Net | $6.4M | 4% |
| Transaction Based Revenue Other Net | $4.1M | 3% |
RGEN
暂无分部数据
